Table 2.
HIV Subjects | Controls | P Value | |
---|---|---|---|
n | 46 | 12 | |
BMI, kg/m2 | 29.7 ± 6.2 | 28.0 ± 5.2 | .29 |
Body fat, % | 32.5 ± 8.9 | 31.8 ± 7.2 | .99 |
Total body mass, kg | 87.1 ± 19.1 | 84.6 ± 17.2 | .74 |
Lean body mass, kg | 54.8 ± 9.9 | 54.1 ± 8.6 | .97 |
Resting energy expenditure, kcal/d | 1772 ± 319 | 1665 ± 150 | .32 |
Respiratory quotient | 0.81 ± 0.05 | 0.79 ± 0.05 | .15 |
Ra glycerol, μmol/kg/min | 3.8 ± 2.2 | 3.6 ± 1.7 | .83 |
Fasting glucose, mg/dL | 97.0 ± 16 | 93.5 ± 9.3 | .77 |
Fasting insulin, μIU/mL | 10.0 ± 9.5 | 8.1 ± 6.9 | .62 |
7.5 [3.1–13.5]a | 6.2 [2.5–11.9]a | ||
Free fatty acid, μEq/L | 0.50 ± 0.22 | 0.55 ± 0.18 | .36 |
Total cholesterol, mg/dL | 172 ± 33 | 181 ± 46 | .44 |
Triglycerides, mg/dL | 130 ± 73 | 154 ± 82 | .38 |
114 [87–153]a | 167 [68–209]a | ||
HDL cholesterol, mg/dL | 50 ± 14 | 41 ± 11 | .11 |
LDL cholesterol, mg/dL | 97 ± 32 | 109 ± 34 | .22 |
MRI measures | |||
Subcutaneous adipose tissue, mL | 659 ± 438 | 604 ± 349 | .89 |
VAT, mL | 573 ± 212 | 492 ± 141 | .34 |
Skeletal muscle fat, % | 2.1 ± 2.5 | 1.6 ± 1.4 | .74 |
1.1 [0.5–2.3]a | 1.2 [0.5–2.0]a | ||
Liver fat, % | 7.5 ± 12.3 | 16.2 ± 19.2 | .03 |
3.6 [1.1–8.3]a | 11.4 [3.0–16.7] | ||
Intramyocardial lipid, % | 1.5 ± 1.4 | 1.4 ± 1.3 | .56 |
1.3 [0.5–2.0]a | 0.7 [0.5–2.3]a |
Abbreviations: HDL, high-density lipoprotein; LDL, low-density lipoprotein. Values represent mean ± standard deviation, unless stated otherwise.
Median [interquartile range].